UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.275-286

2019

Volltextzugriff (PDF)

Expression of inducible nitric oxide synthase in human heart failure

Circulation (New York, N.Y.), 1996-03, Vol.93 (6), p.1087-1094

1996

Volltextzugriff (PDF)

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

BMJ open, 2016-03, Vol.6 (3), p.e010310-e010310

2016

Volltextzugriff (PDF)

Therapeutic potential of nitric oxide synthase gene manipulation

Circulation (New York, N.Y.), 2001-06, Vol.103 (22), p.2760-2765

2001

Volltextzugriff (PDF)

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Liver international, 2024-01, Vol.44 (1), p.139-147

2024

Volltextzugriff (PDF)

Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin

Arteriosclerosis, thrombosis, and vascular biology, 2001-07, Vol.21 (7), p.1152-1158

2001

Volltextzugriff (PDF)

2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A404-A404

2022

Volltextzugriff (PDF)

NO-Synthase und kardiovaskuläre Gentherapie

Clinical research in cardiology, 2001-11, Vol.90 (11), p.807-812

VON DER LEYEN, H. E

2001

Volltextzugriff (PDF)

A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients

EClinicalMedicine, 2021-06, Vol.36, p.100883-100883, Article 100883

2021

Volltextzugriff (PDF)

Cell cycle-dependent regulation of smooth muscle cell activation

Arteriosclerosis, thrombosis, and vascular biology, 2004-05, Vol.24 (5), p.845-850

2004

Volltextzugriff (PDF)

Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients

Trials, 2020-07, Vol.21 (1), p.643-643, Article 643

2020

Volltextzugriff (PDF)

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

Journal of diabetes and its complications, 2023-04, Vol.37 (4), p.108433-108433, Article 108433

2023

Volltextzugriff (PDF)

From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer

BMC cancer, 2015-11, Vol.15 (840), p.842-842, Article 842

2015

Volltextzugriff (PDF)

Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer

EBioMedicine, 2020-11, Vol.61, p.103049, Article 103049

2020

Volltextzugriff (PDF)

Gene Therapy Inhibiting Neointimal Vascular Lesion: In vivo Transfer of Endothelial Cell Nitric Oxide Synthase Gene

Proceedings of the National Academy of Sciences - PNAS, 1995-02, Vol.92 (4), p.1137-1141

1995

Volltextzugriff (PDF)

A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension)

Human gene therapy, 2011-08, Vol.22 (8), p.951-958

2011

Volltextzugriff (PDF)

CCAAT/enhancer-binding protein decoy oligodeoxynucleotide inhibition of macrophage-rich vascular lesion formation in hypercholesterolemic rabbits

Arteriosclerosis, thrombosis, and vascular biology, 2002-06, Vol.22 (6), p.949-954

2002

Volltextzugriff (PDF)

Presence of Retinopathy and Kidney and Cardiovascular Events in Type 2 Diabetes and Normoalbuminuria: A Post Hoc Analysis of the PRIORITY Study: PUB095

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.910-911

2022

Volltextzugriff (PDF)

Effect of Spironolactone Wash-Out on Albuminuria After Long-Term Treatment: The AFTER-PRIORITY Study: SA-PO272

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.677-678

2022

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(71)
Buchkapitel
(2)

Sprache

Englisch
(72)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Expression of inducible nitric oxide synthase in human heart failure

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Therapeutic potential of nitric oxide synthase gene manipulation

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin

2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse

NO-Synthase und kardiovaskuläre Gentherapie

A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients

Cell cycle-dependent regulation of smooth muscle cell activation

Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer

Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer

Gene Therapy Inhibiting Neointimal Vascular Lesion: In vivo Transfer of Endothelial Cell Nitric Oxide Synthase Gene

A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension)

CCAAT/enhancer-binding protein decoy oligodeoxynucleotide inhibition of macrophage-rich vascular lesion formation in hypercholesterolemic rabbits

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

Presence of Retinopathy and Kidney and Cardiovascular Events in Type 2 Diabetes and Normoalbuminuria: A Post Hoc Analysis of the PRIORITY Study: PUB095

Effect of Spironolactone Wash-Out on Albuminuria After Long-Term Treatment: The AFTER-PRIORITY Study: SA-PO272

Suchergebnisse filtern